Market Insights NEWS

Healthcare dealmaking has picked up sharply through the first half of 2026, even as reimbursement pressure, tariff uncertainty, and drug pricing policy continue to create headline risk. Recent midyear outlooks point to a sector that is not pulling back on M&A, but instead getting more selective about where it deploys capital. Biopharma Leads the Charge Biopharma has posted its strongest dealmaking quarter in years, with deal value in the first quarter alone exceeding sixty fi

LabGenomics USA, a subsidiary of South Korea’s LabGenomics, has been strategically expanding its footprint in the U.S. diagnostics...

Abu Dhabi’s e& Group, formerly known as Etisalat, has finalized its acquisition of a controlling stake in PPF Telecom Group’s assets in...

Introduction On October 1, 2024, Powerfleet Inc., a leader in artificial intelligence of things (AIoT) for the fleet management industry,...

Introduction La Française des Jeux (FDJ), France’s national lottery operator and a significant player in the European gaming industry,...

Fabric, a leader in healthcare technology, has announced its acquisition of TeamHealth VirtualCare, a nationwide virtual care provider...

The acquisition of Hawaiian Airlines by Alaska Airlines for $1.9 billion represents a significant shift in the U.S. aviation landscape,...